Table 5.
Group | Resected Patients/All | RO/Resected Patients |
---|---|---|
All patients |
54.2% [41.5%, 66.6%] I2 = 88.7% [82.9%, 92.6%] (n=536) |
80.6% [71.0%, 88.7%] I2 = 72.4% [52.9%, 83.9%] (n=536) |
Group A (resectable before treatment) |
65.8% [55.4%, 75.6%] I2 = 78.2% [58.7%, 88.4%] (n=402) |
85.1% [76.8%, 91.9%] I2 = 65.6% [30.1%, 83.1%] (n=402) |
Group B (borderline/unresectable before treatment) |
31.6% [14.0%, 52.5%] I2 = 84.4% [65.1%, 93.0%] (n=134) |
62.2% [29.9%, 89.4%] I2 = 78.8% [49.3%, 91.1%] (n=134) |